Value, not just floor price
Most Affordable GLP-1 Providers That Are Actually Worth It (2026)
The programs under $300/month tirzepatide or $200/month semaglutide that don't pay for the price with opacity, lock-ins, or dose games.
“Affordable” done honestly is a two-axis question: the all-in price, and what you give up to get it. A rock-bottom figure attached to an unnamed pharmacy, a locked year, or a starter-dose asterisk isn't affordable — it's cheap, which is different. This list filters the field to programs whose verified all-in rate sits under $300/month for tirzepatide or $200 for semaglutide and whose terms survive a close read: honest dose structure, disclosed fees, workable cancellation. Ordered by tirzepatide value first (the molecule most buyers on this page want), each entry states exactly what the low price does and doesn't include.
$215 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $186/mo (12-month plan).
$258 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $225/mo (6-month plan).
$278 a month all-in at the 10 mg maintenance basis, dose-scaled from a $208 entry, including the mandatory $75/mo membership.
$278 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $79/mo membership.
$289 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $169/mo (12-month plan paid up front). Evidence tier: third-party-reported.
$289 a month all-in at the 10 mg maintenance basis, dose-scaled from a $199 entry, no membership fee.
$299 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Figure is company-stated; we could not capture it on a pricing page. Evidence tier: no price published.
$299 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee.
$300 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Evidence tier: third-party-reported.
Semaglutide runs $133 a month all-in. Not available in California; month-to-month runs about $167–$199. No membership fee.
Where “affordable” stops being affordable
Three patterns to price into any low number: memberships that turn $199 into $278 billed (Mochi — though its membership genuinely includes unlimited visits and a company-owned pharmacy, the best value story in the fee-charging tier); prepay locks that make the cheapest rates the least flexible money in the market; and evidence gaps — OrderlyMeds' $299/$149 figures are company-stated but weren't on a pricing page we could capture, and its complaint profile earns a pre-purchase read. When affordability is the whole point, the brand offers deserve one look too: $149 oral Wegovy intro and $299 starter-vial Zepbound are FDA-approved numbers inside this page's range.
The market, in four load-bearing numbers
The floor and the ceiling: NexLife’s $215 flat all-in against LifeMD’s $597 split-billed — $4,584 a year apart for the identical 10 mg basis, which is the whole argument for normalization. Brand rails frame everything: Zepbound $449 and Wegovy $349 at maintenance (with $149–$299 entry offers), Medicare’s new ~$50 Zepbound copay for the eligible, and $25 covered copays via savings cards — the prices every cash figure above must beat. Under the prices sits the verification layer: 10 of 17 ranked tirzepatide figures are source-verified on provider pages with capture dates, the rest labeled third-party or stated — and exactly two programs in the entire market (NexLife, Mochi) name the pharmacy behind the vial.
How to use this page without getting played
Treat every entry as a claim plus its receipts: the price, its basis (all-in, 10 mg, standing), its date, and its evidence tier travel together here — quote them together too. Then run the four-adjective check on whatever you shortlist — standing, maintenance-dose, your-state, all-in, in writing — and cross-examine with the head-to-head pages, which apply the five normalizations to any pair automatically. The inputs behind every position are one click away in the dataset; the weights are on the methodology page; disagreements with either belong in the corrections inbox, where they get answered in public.
Frequently asked
What's the most affordable legit GLP-1 program?
For tirzepatide, NexLife at $215/mo all-in with no membership and a named pharmacy network is the strongest value we can verify; for semaglutide, Oak Longevity at $133 and NexLife at $145–$165 lead.
Are there hidden fees I should expect?
The recurring ones are memberships (always in our all-in figures) and dose-tier increases (flagged per program). One-time intake or lab fees are rarer; confirm both at checkout — and get the maintenance-dose price in writing, not the starter.
Cheapest isn't listed first — why?
Because this page ranks value, not floor price: a $133 starting figure with no maintenance price, or a capped dose, can cost more than a transparent $215 by month four. The pure price ranking lives on the cheapest-tirzepatide page.